Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate whether hCG will result in a decrease in breast
density.
High breast density has been associated with an increased risk in breast cancer. It has also
been shown that decreasing density with a drug called tamoxifen has resulted in a decreased
risk in breast cancer. The investigators are looking at the effect of hCG on breast density
in people who are at increased risk of developing breast cancer and our theory postulates
that through the hormonal actions of hCG and tamoxifen there would be a greater reduction in
breast density in patients who are treated with hCG and tamoxifen versus patients treated
with tamoxifen alone. Using this data the investigators will be able to hypothesize that the
treatment of hCG will result in a reduction in breast cancer rates in the population and thus
make available another drug which can be used to decrease the rates of breast cancer in the
population